2014年5月25日 星期日

學用落差

(http://bme.freebbs.tw 醫學工程論壇 同步發表)


「學用落差因應策略論壇」---

面試亂穿、遲到也不講--->
這可能不是在大學就養成的,是生活及社會教育的氛圍所造成的,強調一如創意工作強調自由性及自主性,結果一堆人只看到舒適面,拿來一體適用,結果呢,就造成這種結果。

大學文憑沒有鑑別度--->
大學真的太多了,碩、博士也是快到這下場了。

機械系竟沒摸過馬達--->
產、官、學界的落差真的是有了,學校老師有時太偏研究,跟實務面脫節很多;所以機械系學生沒摸過馬達,我們醫工科系中電子相關學程的學生沒拿過或不會用烙鐵的,電子零件符號看不懂、不會分辨色碼阻值的有嗎,應該也是有的.......

我個人覺得,以醫工來說,可能有的老師可能太偏研究面,研發、了解產品。但醫工產業還有醫院這一環,醫院裡的醫工及各項制度,真的有多少老師在這方面了解,可以教給學生?
有專業證照加薪一萬---->
科大專注證照沒話說,大學除了研究也是要了解到現實面,但我們的證照呢..


2014年5月10日 星期六

一級召修Hospira Inc., GemStar Docking Station

(http://bme.freebbs.tw 醫學工程論壇 同步發表)

Hospira Inc., GemStar Docking Station (List Number 13075) – Potential for Error or Failure to Power Up (原出處)



搭配使用GemStart使用的Pump座 ,國內沒特別註記有這款QSD申請,但個人認為有時會被認為是配件沒特別申請,直接建議使用,如果各位醫院裡有類似的裝置,建議還是問一下原廠,RECALL的處理狀況。

特別是如果沒QSD的話,要記得撤下勿使用。因為藥事法己修訂,零件、配件、軟體都歸屬QSD管制範圍。


((國內引進的型號13000,13150。13086, 13087, 13088))


Recall Class: Class I
Date Recall Initiated: February 18, 2014
Product: GemStar Docking Station (List Number 13075), used in conjunction with GemStar Infusion Pump
The GemStar Docking Station is a separately sold accessory to the GemStar infusion pump and provides an alternate power source to the GemStar pump
The affected GemStar Docking Station was manufactured from July 2002 through March 2013 and distributed from July 2002 through December 2013.
搭配使用GemStart使用的Pump座 ,會影響所使用的PUMP型號如下表
The products affected by this recall are identified below:
Affected Docking Station ProductCodeWhen Used with These Models of Infusion PumpsWith the Affected List NumbersMay Result in the Following Malfunction
  13075GemStar Phase 3 Pumps13000, 13100, 13150Fail to Power Up
GemStar Phase 3 Pumps or
GemStar Phase 4 Pumps         
13000, 13100, 13150
13086, 13087, 130088
Error Code 11/003
Use: The GemStar Docking Station is used in the post-operative hospital setting where the GemStar pump provides pain/patient control anesthesia (PCA) infusion in combination with other GemStar Accessories. The GemStar pump is often used to inject anesthesia into the spine prior to giving birth. The GemStar pump can also be used for other general infusions such as IV medicines and feeding solutions, antibiotics and cardiovascular solutions.
Recalling Firm:
Hospira Inc.
275 N Field Dr
Lake Forest, Illinois 60045-2579
Reason for Recall:
The firm received customer reports of two potential malfunctions that may occur with the GemStar Docking Station. To date, there have been no reports of death or serious injury associated with these malfunctions.
When the docking station is used with a GemStar Phase 3 pump (List 13000, 13100 or 13150), the GemStar pump may fail to power up while connected to the docking station which may cause a delay of therapy.
When a GemStar Phase 3 pump (List 13000, 13100 or 13150) or GemStar Phase 4 pump (List 13086, 13087 or 13088) is used with both a docking station and an external battery pack accessory (List 13073), there is a possibility that the GemStar pump will display error code 11/003 which will trigger an audible alarm, indicating excessive input voltage (more than 3.6 Volts). The pump will then stop the infusion which may cause a delay of therapy.
The use of this affected product may cause serious adverse health consequences, including death.
Public Contact: For further inquiries, please contact Hospira using the information provided below:
Hospira ContactContact InformationAreas of Support
Hospira Global Complaint
Management
1-800-441-4100 (M-F, 8 am-5pm, CT)
ProductComplaintsPP@hospira.com
To report adverse events
or product complaints
Hospira Advanced
Knowledge Center
1-800-241-4002, option 4
(Available 24 hours a day/7 days a week)
Additional information or
technical assistance
FDA District: Chicago District Office
More Information about this Recall: On February 18, 2014, Hospira sent an Urgent Medical Device Correction letter to all its direct customers. Customers are requested to complete and sign the reply form and return it to the fax number or email address on the form.
Hospira recommends the following:
There is no need to return the GemStar Docking Station at this time.
Healthcare professionals should weigh the risk/benefit to patients associated with the use of the device when administering critical therapies. Customers should consider the use of an alternative pump, particularly in patients in which a delay/interruption in/of therapy could result in serious injury or death.
1. To avoid a failure to power up, turn the pump on first, before connecting the pump with the docking
station. This will prevent the failure to power up.
2. To mitigate the potential for an 11/003 error code, remove the External Battery Pack accessory (list #13073) from the Docking Station and pump prior to installing the pump into the Docking
Station. If you use a Docking station in conjunction with an External Battery Pack accessory (list #13073), this practice should not continue. Please contact Hospira to discuss an appropriate alternative option.
3. Inform potential users in your organization of this notification.
4. Should your facility experience a failure to power up or an 11/003 error code, report the issue to Hospira by calling 1-800-441-4100 (M-F, 8am-5pm,CT) or email ProductComplaintsPP@hospira.com.
5. If you have distributed the product further to the retail level, notify your customers that received the product identified above of this notification and ask them to contact Stericycle at 1-
866-792-5451 (M-F, 8am-5pm ET) to receive a reply form.
About Class I Recalls:Class I recalls are the most serious type of recall and involve situations in which there is a reasonable probability that use of these products will cause serious adverse health consequences or death.
Health care professionals and consumers may report adverse reactions or quality problems they experienced using these products to MedWatch: The FDA Safety Information and Adverse Event Reporting Program either online, by regular mail or by FAX.
Additional Resources: 

2014年5月1日 星期四

聯想召修ThinkPad鋰電池

建議各位夥伴,檢查確認一下各醫療儀器是否有搭配讓款筆電,請公司反應原廠...看是否需要處理
-----------------------------
原文出處

原廠網址

行政院消保處昨指出,荷蘭商聯想公司(Lenovo)主動召回ThinkPad筆電專用的鋰離子電池,消費者如有購買聯想於2010年10月到2011年4月產製的ThinkPad筆電,請儘速與該公司聯繫免費置換,該產品在美國已有2起電池過熱導致電腦、電池及周邊財物受損案例,尚無用戶受傷。
消保處指,台灣有販售受影響的筆電包含用於X201、X201s及Edge 13系列電腦電池,

  • ThinkPad T410, T420, T510, W510, X100E, X120E, X200, X201, X201s Series
  • Edge 11, Edge 13, and Edge 14 Series
  • Option P/Ns 43R9255, 51J0500, 57Y4186, 57Y4564, 57Y4565, 57Y4625, 57Y4559, 43R9254, 0A36277

總計銷售數量為2137個。聯想客服專線02-87615988。

2014年4月3日 星期四

安全警訊 PS500 Power Supply Unit by Dräger: Recall - Early Depletion of Battery Charge


(http://bme.freebbs.tw 醫學工程論壇同步發表)

PS500 Power Supply Unit by Dräger: Recall - Early Depletion of Battery Charge (原出處)

 
  *** 衛署醫器輸字第022952號 *** 台灣德爾鉻醫療器材有限公司
[Posted 04/02/2014]
AUDIENCE: Biomedical Engineering, Nursing, Critical Care Medicine, Risk Manager, Pediatrics
ISSUE: Dräger initiated a nationwide recall of the optional PS500 Power Supply Unit used with the Evita V500 and Babylog VN500 ventilators. The device may not indicate a low battery charge. The first indication of diminished battery capacity may occur when the battery is totally depleted. In some cases, neither the "Battery Low" nor the "Battery Depleted" alarm was triggered when the remaining battery capacity fell below 10%. However, when the battery depleted totally, the power fail alarm was generated.
Should the battery become totally depleted, mechanical ventilation will stop. Manual ventilation will be required until the device is connected to main power.
BACKGROUND: Initial investigation revealed that the battery capacity was reduced due to the occurrence of sulfation within the battery. Frequent short-time use of PS500 battery power can increase sulfation, further reducing the battery capacity. When sufficient sulfation occurs, the connection to main power cannot guarantee fully charged batteries and the charge indicator may not reflect the currently available battery capacity.
This recall only affects Evita V500 and Babylog VN500 ventilators equipped with the optional PS500 power supply unit. Affected devices were distributed nationally between June 2011 and January 2014.
RECOMMENDATION: As an interim solution, the batteries in the PS500 will be replaced free of charge. Until the batteries are exchanged, Dräger recommends that the user:
1. Use an affected device for patient transport only if absolutely necessary.
2. Not rely on the battery charge status indicator.
3. Always supervise the patient and the ventilator during transport. Ensure that a manual resuscitator is available for manual ventilation, as recommended in the instructions for use.
4. If the power failure alarm occurs during transport, immediately provide manual ventilation and connect the ventilator to a wall power source to resume ventilation.
After the above mentioned battery exchange, Dräger recommends the following:
1. Minimize battery usage.
2. Avoid brief usage and charging of the PS500 (1 – 20 minutes).
3. Avoid patient transport lasting longer than 1 hour.
4. Make sure to charge the batteries for at least 24 hours.
The exchange of the existing batteries and the above recommendations are only a temporary solution to ensure a minimum operating time of 1 hour independent from main AC power. The permanent solution, once available, will also be provided free of charge.
A recall notification has been sent to all current users of the recalled Evita 500 and Babylog VN500 ventilators and is available on the Dräger website at www.draeger.com. Users are being contacted by a Dräger Service representative to schedule the replacement of the PS500 batteries free of charge.
For questions regarding the operation and/or servicing of affected Dräger ventilators in the United States, call Dräger Service Technical Support at 1-800-543-5047 (press 4 at the prompt) between the hours of 8AM to 8PM EDT Monday through Friday, or contact Dräger by email at info.usa@draeger.com.

Healthcare professionals and patients are encouraged to report adverse events or side effects related to the use of these products to the FDA's MedWatch Safety Information and Adverse Event Reporting Program:
  • Complete and submit the report Online: www.fda.gov/MedWatch/report.htm
  • Download form or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178
[04/02/2014 -Firm Press Release - Dräger]

2014年4月2日 星期三

一級召修 Thoratec Corporation, HeartMate II LVAS Pocket System Controller


(http://bme.freebbs.tw 醫學工程論壇同步發表)






Recall Class: Class I
Date Recall Initiated: March 4, 2014
Catalog Numbers:106015 and 106016 – HeartMate II LVAS Implant Kit with Pocket Controller
106762 and 106017 – HeartMate II LVAS Pocket System Controller
107801 – HeartMate II LVAD Pump and Pocket Controller Kit
105109 – Pocket System Controller removed from packaging
Distribution Dates: August 2012 – June 2014
Use: The Pocket System Controller is a power supply that connects to the implanted HeartMate II LVAS pump through a lead (driveline) under the skin. The controller helps power the LVAS system, a mechanical device that circulates blood throughout the body when the heart is too weak to pump blood adequately on its own. The controller is powered by batteries or connected to a main power supply.
A back-up system controller is provided for use in case of a device alarm or malfunction. Instructions and training are provided on how to switch from one system to the other.
Recalling Firm:Thoratec Corporation
6035 Stoneridge Drive
Pleasanton, CA 94588-3270
Reason for Recall:Thoratec has received five reports of serious injury and four reports of death associated with difficulty in changing from the primary system controller to a back-up system controller. All reports were linked to patients whose HeartMate II LVAS device was originally attached to an older model of controller, the EPC System controller. When the Pocket System Controller became available, patients were switched from the EPC System Controller to the Pocket System Controller. However, these patients did not receive intensive training on connecting the new controller. The design differences between the EPC System Controller and the Pocket System Controller require a different approach to how the device is connected. If the controller is not properly connected, the device cannot function.
The use of this product may cause serious adverse health consequences, including death.
Public Contact:Individuals with questions regarding this recall may contact Thoratec Corporation at 800-528-2577 or 925-847-8600, 7 days per week, 8:00 AM – 5:00 PM, Pacific Time.
FDA District: San Francisco District Office
More Information about this Recall: On March 4, 2014, Thoratec Corporation sent an "Urgent Medical Device Correction" letter by email to all affected customers. Customers were requested to complete and sign an Acknowledgement Letter that was attached to the email and return it to Thoratec via FAX or scanned email copy.
The letter identified the product, problem and the actions to be taken:
  • Physicians who prescribe the HeartMate II LVAS Pocket Controller should immediately review the updated labeling and training materials provided in the Urgent Medical Device Correction Letter with all clinical personnel responsible for training patients and caregivers on the use of the Pocket System Controller.
  • All patients using the Pocket System Controller and their caregivers should be retrained on the use of the device and be provided with updated Patient Handbook information.
  • Thoratec plans to update labeling and training materials for the device to provide better instruction on connecting the driveline to the Pocket System Controller.
About Class I RecallsClass I recalls are the most serious type of recall and involve situations in which there is a reasonable probability that use of these products will cause serious adverse health consequences or death.
Health care professionals and consumers may report adverse reactions or quality problems they experienced using these products to MedWatch: The FDA Safety Information and Adverse Event Reporting Program either online, by regular mail or by FAX.

2014年3月17日 星期一

Toshiba DXB-0324CS管球(Varian)拆解

(http://bme.freebbs.tw 醫學工程論壇同步發表)

名稱: Toshiba DXB-0324CS管球(Varian)拆解

故障情形:正常損耗

故障原因:正常損耗

管球有沒有學校想要當教學用的,免費提供哦,但要自取。
 

 


2014年3月8日 星期六

一級召修 Philips Respironics, Trilogy Ventilator, Models 100, 200, and 202 - Failure to Deliver Mechanical Breaths

(http://bme.freebbs.tw 醫學工程論壇 同步發表)

一級召修 Philips Respironics, Trilogy Ventilator, Models 100, 200, and 202 - Failure to Deliver Mechanical Breaths

一級召修
 廠牌:Philips Respironics,
 型號:Trilogy Ventilator, Models 100, 200, and 202
 狀況: Failure to Deliver Mechanical Breaths
 產品批次: 2013-12-31 ~ 2014-01-30
 召修原因: There is a potentially defective component on the Trilogy Ventilator power management board which could affect the function of the device.(電源電路板有潛在問題)
原文連結

Trilogy Ventilator, 

 

Models 100,

*** 衛署醫器輸字第020619號 *** 嘉杏股份有限公司

*** 衛署醫器輸字第021289號 *** 嘉杏股份有限公司

Models 200 *** 衛署醫器輸字第021689號 *** 亞靖儀器有限公司

Models 202 *** 衛署醫器輸字第022329號 *** 台灣飛利浦股份有限公司

Recall Class: Class I
Date Recall Initiated:  February 11, 2014
Product: Trilogy Ventilator, Models 100, 200, and 202
The affected models were manufactured and distributed from December 31, 2013 through January 30, 2014.
The serial numbers of the affected devices are located on the back of the device.  See photo under Additional Links below.
Use: The Philips Respironics Trilogy Ventilator is intended to provide continuous or intermittent ventilatory support for the care of individuals who require mechanical ventilation.
The devices are intended to be used in home, institution/hospital, and portable applications such as wheelchairs and gurneys.
Recalling Firm:
Phillips Respironics, Inc.
1001 Murry Ridge Lane
Murrysville, Pennsylvania 15668-8517
Reason for Recall: There is a potentially defective component on the Trilogy Ventilator power management board which could affect the function of the device. If this issue is not corrected it is possible that the ventilator may fail to deliver mechanical breaths and that the alarm functionality may be reduced to indicate ventilatory failure, resulting in serious adverse health consequences or death.
During production testing Philips Respironics discovered that the affected Trilogy ventilators contain a potentially defective ferrite component on the power management board of the device.
Public Contact: Customers who have questions about this recall, require further information or support concerning this issue, may contact their local Philips Respironics representative through the Customer Care Center, 1-800-345-6443, available 24/7.
FDA District: Philadelphia District Office
FDA Comments:  
On February 11, 2014 the firm initiated the recall by phoning their direct customers who are primarily wholesale dealers of home healthcare products. The firm followed up their phone calls by sending recall notification letters to their customers. On February 19, 2014, the firm issued a press release to notify consumers about the recall. 
Philips Respironics is instructing customers to remove the affected devices from service and to return them to Philips for replacement. All distributors, providers, and customers with potentially affected Trilogy devices will have their units replaced.
Class I recalls are the most serious type of recall and involve situations in which there is a reasonable probability that use of these products will cause serious adverse health consequences or death.
Health care professionals and consumers may report adverse reactions or quality problems they experienced using these products to MedWatch: The FDA Safety Information and Adverse Event Reporting Program either online, by regular mail or by FAX.
Additional Links: